Library / Laws / 119th Congress / House Bills / H.R. 2542
H.R. 2542
To amend titles XVIII and XIX of the Social Security Act to provide that priority research drugs shall not be treated as line extensions of existing drugs for purposes of calculating manufacturer rebates under the Medicare and Medicaid programs, and for other purposes.
| Print stage | Date | Size | ⠃ |
|---|---|---|---|
| Introduced in House | 2025-04-01 | 4.0K | ⠃⠗⠋ |